Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 06:10 am Purchase | 2026-06-30 | 13G | BEYOND AIR INC XAIR | BALYASNY ASSET MANAGEMENT L.P. | 763,266 5.300% | 725,103 (+1900.02%) | Filing History |
| 2026-08-14 06:10 am Purchase | 2026-06-30 | 13G | TXNM ENERGY, INC. TXNM | BALYASNY ASSET MANAGEMENT L.P. | 7,113,061 6.430% | 5,876,352 (+475.16%) | Filing History |
| 2026-08-14 06:09 am Sale | 2026-06-30 | 13G | TALKSPACE INC TALK | BALYASNY ASSET MANAGEMENT L.P. | 6,857,833 4.090% | -2,008,894 (-22.66%) | Filing History |
| 2026-08-14 06:09 am Purchase | 2026-06-30 | 13G | SKYWATER TECHNOLOGY INC SKYT | BALYASNY ASSET MANAGEMENT L.P. | 3,122,552 6.350% | 3,122,552 (New Position) | Filing History |
| 2026-08-14 06:09 am Purchase | 2026-06-30 | 13G | SAGIMET BIOSCIENCES INC SER A SGMT | BALYASNY ASSET MANAGEMENT L.P. | 3,626,113 5.930% | 3,626,113 (New Position) | Filing History |
| 2026-08-14 06:08 am Purchase | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BALYASNY ASSET MANAGEMENT L.P. | 7,225,439 9.450% | 2,135,500 (+41.96%) | Filing History |
| 2026-08-14 06:08 am Sale | 2026-06-30 | 13G | REZOLUTE INC RZLT | BALYASNY ASSET MANAGEMENT L.P. | 4,662,039 4.840% | -386,382 (-7.65%) | Filing History |
| 2026-08-14 06:08 am Sale | 2026-06-30 | 13G | RALLYBIO CORP COM RLYB | BALYASNY ASSET MANAGEMENT L.P. | 0 0.000% | -376,573 (Position Closed) | Filing History |
| 2026-08-14 06:07 am Purchase | 2026-06-30 | 13G | RESEARCH ALLIANCE CORP III CL RACC | BALYASNY ASSET MANAGEMENT L.P. | 500,000 6.430% | 500,000 (New Position) | Filing History |
| 2026-08-14 06:07 am Purchase | 2026-06-30 | 13G | QUINCE THERAPEUTICS INC PA QNCX | BALYASNY ASSET MANAGEMENT L.P. | 97,699 9.990% | 97,699 (New Position) | Filing History |
| 2026-08-14 06:06 am Purchase | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | BALYASNY ASSET MANAGEMENT L.P. | 9,313,341 4.990% | 2,284,118 (+32.49%) | Filing History |
| 2026-08-14 06:06 am Sale | 2026-06-30 | 13G | NASUS PHARMA LTD NSRX | BALYASNY ASSET MANAGEMENT L.P. | 1,169,909 9.990% | -1 (-0.00%) | Filing History |
| 2026-08-14 06:05 am Purchase | 2026-06-30 | 13G | NEUROGENE INC NGNE | BALYASNY ASSET MANAGEMENT L.P. | 818,706 5.180% | 818,706 (New Position) | Filing History |
| 2026-08-14 06:05 am Purchase | 2026-06-30 | 13G | MINERVA NEUROSCIENCES INC NERV | BALYASNY ASSET MANAGEMENT L.P. | 4,654,212 9.990% | 331,100 (+7.66%) | Filing History |
| 2026-08-14 06:04 am Purchase | 2026-06-30 | 13G | LEXEO THERAPEUTICS INC LXEO | BALYASNY ASSET MANAGEMENT L.P. | 7,844,311 9.990% | 668,167 (+9.31%) | Filing History |
| 2026-08-14 06:04 am Sale | 2026-06-30 | 13G | KORRO BIO INC KRRO | BALYASNY ASSET MANAGEMENT L.P. | 951,783 6.600% | -88,271 (-8.49%) | Filing History |
| 2026-08-14 06:04 am Purchase | 2026-06-30 | 13G | JATT II ACQUISITION CORP USD O JATT | BALYASNY ASSET MANAGEMENT L.P. | 500,000 6.230% | 500,000 (New Position) | Filing History |
| 2026-08-14 06:03 am Purchase | 2026-06-30 | 13G | OPUS GENETICS, INC. IRD | BALYASNY ASSET MANAGEMENT L.P. | 5,480,210 6.640% | 369,837 (+7.24%) | Filing History |
| 2026-08-14 06:03 am Sale | 2026-06-30 | 13G | TXNM ENERGY, INC. TXNM | BALYASNY ASSET MANAGEMENT L.P. | 1,236,709 6.970% | -791 (-0.06%) | Filing History |
| 2026-08-14 06:02 am Purchase | 2026-06-30 | 13G | CYCLERION THERAPEUTICS INC CYCN | BALYASNY ASSET MANAGEMENT L.P. | 317,511 7.330% | 317,511 (New Position) | Filing History |